全国服务咨询热线：
18438616290
18438616290
产品分类
Product Category详细介绍
| 品牌 | absin | CAS | 95734-82-0 |
|---|---|---|---|
| 分子式 | C2H8N2O3Pt | 纯度 | ＞98% |
| 分子量 | 303.18 | 货号 | abs47028039 |
| 规格 | 5mg | 供货周期 | 现货 |
| 主要用途 | is a derivative of cisplatin | 应用领域 | 化工,生物产业,农林牧渔,制药/生物制药,综合 |
Nedaplatin 95734-82-0
| 产品描述 | |
| 描述 | Nedaplatin (NSC 375101D) is a derivative of cisplatin and DNA damage agent. |
| 纯度 | ＞98% |
| 储存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 别名 | 奈da铂；顺糖an铂;NSC 375101D |
| 外观 | 稻黄色粉末 |
| 可溶性/溶解性 | Water : 15 mg/mL (49.5 mM) |
| 生物活性 | |
| 靶点 | DNA synthesis |
| In vitro(体外研究) | Nedaplatin (Aqupla) is a derivative of cisplatin for inhibition of tumor colony forming units with IC50 of 28.5 μg/mL. Nedaplatin is a platinum compound which is used for cancer chemotherapy. Nedaplatin inhibits the proliferation of SBC-3 cells by 98%, 93%, 75%, 54%, 27%, 6%, and 2% at a concentration of 0.005 μg/mL, 0.01 μg/mL, 0.025 μg/mL, 0.05 μg/mL, 0.1 μg/mL, 0.25 μg/mL, and 0.5 μg/mL, respectively. The IC50 value of Nedaplatin for growth inhibition of SBC-3 cells is 0.053 μg/mL. |
| In vivo(体内研究) | The sequential administration of 5-FU prior to nedaplatin or CDDP (FN or FC therapy) results in synergistically enhanced inhibition of tumour growth and prolonged survival in comparison with nedaplatin, CDDP or 5-FU monotherapy. Combined dosing of Nedaplatin with gemcitabine results in synergistically enhanced inhibition of tumor growth in the Ma44 tumor model. Nedaplatin plus Gemcitabine is also effective against Ma44 cells when given late in the therapy, a model for advanced disease. Potent augmentation of growth inhibition by Nedaplatin with Gemcitabine is also found with the NCI-H460 tumor model. |
| 研究领域 | |
| 研究领域 | CancerCancer Metabolism Drug DiscoverySmall Molecule DrugLead Compound Discovery |
产品咨询
地址：上海市浦东新区新浩路58号申江科创园18栋
邮箱：lanwu@univ-bio.com
传真：